Incyte CEO on New Drugs, Jakafi Applications

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Feb. 20 (Bloomberg) -- Herve Hoppenot, chief executive officer of Incyte Corp., talks with Bloomberg’s Meg Tirrell about the company's Jakfi drug used to treat a bone marrow disorder called myelofibrosis, Incyte's drug pipeline and the outlook for growth. Shares of the cancer-drug maker have tripled in the last year. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change